Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts ; volume:9 ; number:1 ; day:27 ; month:6 ; year:2010 ; pages:1-8 ; date:12.2010
Molecular cancer ; 9, Heft 1 (27.6.2010), 1-8, 12.2010
- Urheber
-
Haubeiss, Silke
Schmid, Jens O.
Mürdter, Thomas E.
Sonnenberg, Maike
Friedel, Godehard
van der Kuip, Heiko
Aulitzky, Walter E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-9-168
- URN
-
urn:nbn:de:101:1-2021082421153891544979
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Haubeiss, Silke
- Schmid, Jens O.
- Mürdter, Thomas E.
- Sonnenberg, Maike
- Friedel, Godehard
- van der Kuip, Heiko
- Aulitzky, Walter E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biomarkers for cancer-associated fibroblasts
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer‐associated fibroblasts: activin A adds another string to their bow
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Advances of cancer-associated fibroblasts in liver cancer
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Comparative transcriptome of normal and cancer-associated fibroblasts
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Biomarkers for cancer-associated fibroblasts
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer‐associated fibroblasts: activin A adds another string to their bow
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Advances of cancer-associated fibroblasts in liver cancer
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Comparative transcriptome of normal and cancer-associated fibroblasts
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Biomarkers for cancer-associated fibroblasts
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer‐associated fibroblasts: activin A adds another string to their bow
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Advances of cancer-associated fibroblasts in liver cancer
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Comparative transcriptome of normal and cancer-associated fibroblasts
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts